Article

Molecular subtyping improves prognostication of Stage 2 colorectal cancer

2019-11-05

Abstract excerpt

<title>Abstract</title> <p>Background: Post-surgical staging is the mainstay of prognostic stratification for colorectal cancer (CRC). Here, we compare TNM staging to consensus molecular subtyping (CMS) and assess the value of subtyping in addition to stratification by TNM. <h4>Methods:</h4> Three hundred and eight treatment-naïve colorectal tumours were accessed from our institutional tissue bank. CMS typing was...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 944209b8-72c6-5e8c-916c-6e3b797c8e8a
DOI: 10.21203/rs.2.14003/v3

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Molecular subtyping improves prognostication of Stage 2 colorectal cancerDOI 10.21203/rs.2.14003/v3Read

Molecular subtyping improves prognostication of Stage 2 colorectal cancerSemantic proximity Read

Interconnectivity between molecular subtypes and tumor stage in colorectal cancerSemantic proximity Read

Reconciliation of classification systems defining molecular subtypes of colorectal cancerSemantic proximity Read

Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer.Semantic proximity Read

Molecular-Subtype-Specific Biomarkers Improve Prediction of Prognosis in Colorectal CancerSemantic proximity Read

CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical modelsSemantic proximity Read

Consensus molecular subtyping in colon cancer: from the design of in-house assay to prognostic nomogramSemantic proximity Read

Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtypeSemantic proximity Read

Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.Semantic proximity Read

Molecular profiling of risk factors for relapse in Japanese patients with stage II colorectal cancer: a retrospective cohort study.Semantic proximity Read

Context matters-consensus molecular subtypes of colorectal cancer as biomarkers for clinical trials.Semantic proximity Read

Gene expression biomarkers differentiate overall survival of colorectal cancer upon targeted therapiesSemantic proximity Read